Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Tumor Size Reduction and Serum Carbohydrate Antigen 19-9 Kinetics After Neoadjuvant FOLFIRINOX in Patients With Pancreatic Ductal Adenocarcinoma.
Authors: Servin-Rojas M; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: http://www.twitter.com/servinrojasmd., Fong ZV; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: http://www.twitter.com/zhivenfongmd., Fernandez-Del Castillo C; Department of Surgery, Massachusetts General Hospital, Boston, MA., Ferrone CR; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: http://www.twitter.com/cferronemd., Lee H; Department of Biostatistics, Massachusetts General Hospital, Boston, MA., Lopez-Verdugo F; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: http://www.twitter.com/fidel_lv., Qiao G; Department of Surgery, Massachusetts General Hospital, Boston, MA., Rocha-Castellanos DM; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: http://www.twitter.com/dariorochamd., Lillemoe KD; Department of Surgery, Massachusetts General Hospital, Boston, MA., Qadan M; Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: mqadan@mgh.harvard.edu.
Source: Surgery [Surgery] 2024 Feb; Vol. 175 (2), pp. 471-476. Date of Electronic Publication: 2023 Nov 10.
Publication Type: Journal Article
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0417347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-7361 (Electronic) Linking ISSN: 00396060 NLM ISO Abbreviation: Surgery Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-7361
DOI:10.1016/j.surg.2023.09.041